Scworx Corp

Scworx Corp(WORX)の株式分析

$1.380

-0.432 (-31.34%)終値時点

Loading chart…
高値
3.770
始値
2.080
出来高加重平均価格
2.07
出来高
8.73M
時価総額
2.08M
安値
1.070
売買代金
18.10M
EV/EBITDA(TTM)
0.00

SCWorx Corp. is a provider of data content and services related to the repair, normalization and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. The Company has developed and markets health care information technology solutions and associated services that enhance healthcare processes and information flow within hospitals and other healthcare facilities. Its software enables a healthcare provider to simplify and organize its data (data normalization), allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics (big data). Its software modules include virtualized item master file repair, expansion and automation, electronic medical record management, charge description master management, contract management, request for proposal (RFP) automation, integration of acquired businesses, rebate management, and data integration and warehousing.

www.scworx.com

AI分析 of Scworx Corp (WORX)

売り

Scworx Corp (WORX) is not a good buy right now due to significant losses and declining performance metrics. The current price is $3.73, with a staggering year-to-date change of -89.79%. Additionally, the RSI is at a very low 7.101, indicating extreme oversold conditions, but this could also suggest continued downward pressure. The gross margin has improved to 45.53% in Q4 2025, but the company is still facing substantial net losses, with a net income of -749182 USD in the same quarter. The main risk is the ongoing negative sentiment reflected in the stock's performance, with a 5-day change of -81.04%.

バリュエーション指標

Scworx Corp(WORX)の現在の予想PERは0.00で、5年平均は0.00です。

予想PER

大幅な割安
5年平均 P/E
0.00
現在のP/E
0.00
割高
0.00
割安
0.00

予想EV/EBITDA

大幅な割安
5年平均 EV/EBITDA
0.00
現在のEV/EBITDA
0.00
割高
0.00
割安
0.00

予想PSR

大幅な割安
5年平均 P/S
0.00
現在のP/S
0.00
割高
0.00
割安
0.00

Alphio AI による WORX の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%WORX

$0.50

シナリオ価格

基

基本

基本 · 50%WORX

$0.50

シナリオ価格

弱

弱気

弱気 · 25%WORX

$0.42

シナリオ価格

イベントタイムライン

2026-10-08 (ET)

12:30:00

Scworx Corp Trading Halted Due to Volatility

12:30:00

Scworx Corp Trading Resumes

2026-10-05 (ET)

13:30:00

SCWorx Granted Continued Listing on Nasdaq

2026-08-06 (ET)

11:30:00

SCWorx Signs Two-Year Agreement with Major Massachusetts Healthcare Network

2026-06-30 (ET)

11:00:00

SCWorx Secures Data Management Agreement with Non-Profit Hospital

ニュース

WORX のよくある質問 — Alphio AI が回答

SCWorx Corp. is a provider of data content and services related to the repair, normalization and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. The Company has developed and markets health care information technology solutions and associated services that enhance healthcare processes and information flow within hospitals and other healthcare facilities. Its software enables a healthcare provider to simplify and organize its data (data normalization), allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics (big data). Its software modules include virtualized item master file repair, expansion and automation, electronic medical record management, charge description master management, contract management, request for proposal (RFP) automation, integration of acquired businesses, rebate management, and data integration and warehousing. It operates in the Industrials sector (SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION industry).

Scworx Corp (WORX) is not a good buy right now due to significant losses and declining performance metrics. The current price is $3.73, with a staggering year-to-date change of -89.79%. Additionally, the RSI is at a very low 7.101, indicating extreme oversold conditions, but this could also suggest continued downward pressure. The gross margin has improved to 45.53% in Q4 2025, but the company is still facing substantial net losses, with a net income of -749182 USD in the same quarter. The main risk is the ongoing negative sentiment reflected in the stock's performance, with a 5-day change of -81.04%.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める